Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$689,506
-$223,880 QoQ
Shares Held
28,634
-12.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#1,544
of 2,821 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026VeraBank, N.A. holds $15,922,408 across 9 Drug Manufacturers - General names. PFE ranks #7 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
14,786 | $3,755,200 | |
| 2 | ABBV |
AbbVie Inc.
|
14,486 | $3,645,256 | |
| 3 | LLY |
ELI LILLY & Co
|
2,632 | $3,156,900 | |
| 4 | AMGN |
Amgen Inc
|
4,636 | $1,678,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,222 | $1,313,526 | |
| 6 | GSK |
GSK plc
|
20,501 | $1,074,662 | |
| 7 | PFE |
Pfizer Inc
This page
|
28,634 | $689,506 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,797 | $353,372 |
All Filings in PFE
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $689,506 | 28,634 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $913,386 | 32,528 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $994,182 | 39,927 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $1,026,385 | 40,282 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $983,368 | 40,568 | Shares | Other | 2025-08-08 | |
| 2025-03-31 | $809,435 | 31,943 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $847,447 | 31,943 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,014,289 | 35,048 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $1,027,509 | 36,723 | Shares | Sole | 2024-07-24 | |
| 2024-03-31 | $1,055,138 | 38,023 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $1,114,374 | 38,707 | Shares | Other | 2024-02-06 | |
| 2023-09-30 | $1,365,011 | 41,152 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $1,492,619 | 40,693 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,894,711 | 46,439 | Shares | Other | 2023-04-20 | |
| 2022-12-31 | $2,379,534 | 46,439 | Shares | Other | 2023-01-25 | |
| 2022-09-30 | $2,032,214 | 46,440 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $2,434,849 | 46,440 | Shares | Sole | 2022-07-28 | |
| 2022-03-31 | $2,283,574 | 44,110 | Shares | Sole | 2022-04-27 | |
| 2021-12-31 | $2,651,404 | 44,901 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $1,931,192 | 44,901 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,757,187 | 44,872 | Shares | Other | 2021-08-04 | |
| 2021-03-31 | $1,576,802 | 43,522 | Shares | Sole | 2021-04-13 | |
| 2020-12-31 | $1,563,651 | 42,479 | Shares | Sole | 2021-01-29 | |
| 2020-09-30 | $1,556,628 | 42,415 | Shares | Sole | 2020-10-16 | |
| 2020-06-30 | $1,391,059 | 42,540 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $1,357,821 | 41,600 | Shares | Sole | 2020-04-21 | |
| No filing history on record for this holder in this stock. | ||||||